1:47 PM
 | 
Jan 03, 2018
 |  BC Extra  |  Financial News

Boehringer Ingelheim enlarges investment fund

Boehringer Ingelheim GmbH (Ingelheim, Germany) added €150 million ($178.1 million) to its Boehringer Ingelheim Venture Fund, boosting its total to €250 million ($296.9 million), and is expanding the fund's investment focus to include regenerative medicine, infectious diseases and digital health start-ups.

Boehringer is also doubling...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >